Molecular Partners Ag MOLN
NASDAQ MOLN
$4.40 +0.17 (+4.02%)
As of: Aug 21, 2026 · 12:43 PM EDT

Molecular Partners Ag (MOLN) Profit After Tax (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Profit After Tax of -$16784.9 for Q1 2026, up 10.02% year-over-year from -$15256.6 in Q1 2025, and up 99.98% quarter-over-quarter from -$77.1 million in Q4 2025.

Molecular Partners Ag (MOLN) Profit After Tax (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Profit After Tax for 7 consecutive years, with -$16784.9 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Profit After Tax rose 10.02% year-over-year to -$16784.9; the TTM figure through Mar 2026 stood at -$77.2 million (down 214.24% YoY), while the FY2025 annual figure was -$77.2 million, down 214.23% from the prior year.
  • Profit After Tax climbed to -$16784.9 in Q1 2026 per MOLN's latest filing, from -$77.1 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $122.2 million in Q4 2022 and bottomed at -$77.1 million in Q4 2025.
  • Historically, Profit After Tax has averaged $1.2 million across 5 years, with a median of -$16677.6 in 2024.
  • Annual changes were most pronounced in 2022 — Profit After Tax soared 1020.39% — and 2023, when it sank 278.7%.
  • Molecular Partners Ag's Profit After Tax stood at $122.2 million in 2022, then plunged by 157.15% to -$69.8 million in 2023, then jumped by 196.84% to $67.6 million in 2024, then tumbled by 214.06% to -$77.1 million in 2025, then soared by 99.98% to -$16784.9 in 2026.
  • Business Quant data shows MOLN's Profit After Tax at -$16784.9 in Q1 2026, -$77.1 million in Q4 2025, and -$15258.8 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Molecular Partners Ag 163.99 Mn 163.99 Mn - -16,784.95

Historic Data

Download Data
DateValue
Mar 31, 2026 -16,784.95
Dec 31, 2025 -77.14 Mn
Sep 30, 2025 -15,258.84
Jun 30, 2025 -27,182.36
Mar 31, 2025 -18,653.55
Dec 31, 2024 67.63 Mn
Sep 30, 2024 -20,607.22
Jun 30, 2024 -16,677.58
Mar 31, 2024 -12,974.85
Dec 31, 2023 -69.83 Mn
Sep 30, 2023 -12,950.69
Jun 30, 2023 -17.78 Mn
Mar 31, 2023 -15,977.42
Dec 31, 2022 122.19 Mn
Sep 30, 2022 -15,424.16
Jun 30, 2022 -4.70 Mn
Mar 31, 2022 168,520.72
Dec 31, 2021 -69.13 Mn
Sep 30, 2021 -13,406.09
Jun 30, 2021 -36.79 Mn